clinical trial · NCT06698016
A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)
Merck Sharp & Dohme LLC·phase1·completed·n = 16
HealthyNemtabrutinibEfavirenz
brief summary
The goal of the study is to learn what happens to levels of nemtabrutinib (MK-1026) in a healthy person's body over time. Researchers will compare what happens to nemtabrutinib in the body when it is given with or without another medicine called efavirenz.
started
Jul 25, 2023
primary completion
Oct 30, 2023
completion
Oct 30, 2023
last updated
Nov 20, 2024
official title
A Study to Evaluate the Effect of Multiple Oral Doses of Efavirenz on the Single-Dose Pharmacokinetics of Nemtabrutinib in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol